Carmot Therapeutics' Series A - II Round

Carmot Therapeutics raised a round of funding on December 21, 2010. Investors include Leader Ventures.

Carmot Therapeutics is applying its technology, Chemotype Evolution, to address unmet chemical needs in drug discovery, focusing on high-profile targets for which drug leads have been difficult to ide…

Articles about Carmot Therapeutics' Series A - II Round: